KNBIF (Kane Biotech) 3-Year Share Buyback Ratio: -13.30% (As of Mar. 2026)


What is Kane Biotech 3-Year Share Buyback Ratio?

Kane Biotech KNBIF -13.33% 3-Year Share Buyback Ratio is -13.30 as of Mar. 2026. The stock has 6 warning signs investors should review. Among 1,193 Biotechnology companies, Kane Biotech ranks worse than 53.06% on this metric.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Kane Biotech's current 3-Year Share Buyback Ratio was -13.30%.

The historical rank and industry rank for Kane Biotech's 3-Year Share Buyback Ratio or its related term are showing as below:

KNBIF' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -48.5   Med: -20.4   Max: -6.3
Current: -13.3

During the past 13 years, Kane Biotech's highest 3-Year Share Buyback Ratio was -6.30%. The lowest was -48.50%. And the median was -20.40%.

KNBIF's 3-Year Share Buyback Ratio is ranked worse than
53.06% of 1193 companies
in the Biotechnology industry
Industry Median: -11.8 vs KNBIF: -13.30

Kane Biotech (OTCPK:KNBIF) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Kane Biotech 3-Year Share Buyback Ratio Related Terms

KNBIF vs VRTX, REGN, ALNY: 3-Year Share Buyback Ratio Comparison

For the Biotechnology subindustry, Kane Biotech's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kane Biotech 3-Year Share Buyback Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kane Biotech's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Kane Biotech's 3-Year Share Buyback Ratio falls into.


Kane Biotech 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

What does a 3-Year Share Buyback Ratio of -13.30 mean?
Kane Biotech (KNBIF) has a 3-Year Share Buyback Ratio of -13.30 as of Mar. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Kane Biotech and its competitors. According to the industry distribution chart, Kane Biotech ranks #633 out of 1193 companies in the Biotechnology industry, placing it in the top 53.1%.
Is Kane Biotech's 3-Year Share Buyback Ratio too high?
Kane Biotech's current 3-Year Share Buyback Ratio is -13.30. Based on the distribution chart, Kane Biotech ranks #633 out of 1193 companies in the Biotechnology industry, which is below the industry midpoint.
How does Kane Biotech's 3-Year Share Buyback Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kane Biotech ranks #633 out of 1193 companies for 3-Year Share Buyback Ratio. This places Kane Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Biotechnology company?
A good 3-Year Share Buyback Ratio depends on the Biotechnology industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Kane Biotech and its competitors. Kane Biotech's current 3-Year Share Buyback Ratio is -13.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current 3-Year Share Buyback Ratio of -13.30. The current 3-Year Share Buyback Ratio is -13.30. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current 3-Year Share Buyback Ratio is -13.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.